Wix.com (WIX) Stock “Neutral” Rating Reiterated at Citigroup; The Target Price Given is $78; CRYO-CELL INTERNATIONAL (CCEL) Sellers Increased By 50% Their Shorts

February 21, 2018 - By Darrin Black

Among 14 analysts covering Wix.com (NASDAQ:WIX), 9 have Buy rating, 0 Sell and 5 Hold. Therefore 64% are positive. Wix.com has $90.0 highest and $27 lowest target. $66.14’s average target is -13.43% below currents $76.4 stock price. Wix.com had 34 analyst reports since August 6, 2015 according to SRatingsIntel. RBC Capital Markets downgraded the shares of WIX in report on Friday, September 23 to “Sector Perform” rating. The rating was downgraded by Raymond James on Thursday, April 13 to “Market Perform”. Cantor Fitzgerald downgraded Wix.com Ltd. (NASDAQ:WIX) on Tuesday, April 11 to “Neutral” rating. The rating was maintained by Deutsche Bank with “Hold” on Thursday, August 6. The rating was initiated by Cantor Fitzgerald on Wednesday, October 19 with “Buy”. The rating was maintained by Oppenheimer on Tuesday, July 25 with “Buy”. The rating was maintained by RBC Capital Markets with “Outperform” on Thursday, November 5. On Monday, November 6 the stock rating was maintained by SunTrust with “Buy”. The firm earned “Market Outperform” rating on Tuesday, November 24 by JMP Securities. The stock of Wix.com Ltd. (NASDAQ:WIX) has “Overweight” rating given on Thursday, November 9 by Barclays Capital.

CRYO-CELL INTERNATIONAL INC (OTCMKTS:CCEL) had an increase of 50% in short interest. CCEL’s SI was 300 shares in February as released by FINRA. Its up 50% from 200 shares previously. With 3,400 avg volume, 0 days are for CRYO-CELL INTERNATIONAL INC (OTCMKTS:CCEL)’s short sellers to cover CCEL’s short positions. The SI to CRYO-CELL INTERNATIONAL INC’s float is 0.01%. The stock decreased 4.26% or $0.38 during the last trading session, reaching $8.54. About 2,390 shares traded or 20.89% up from the average. Cryo-Cell International, Inc. (OTCMKTS:CCEL) has 0.00% since February 21, 2017 and is . It has underperformed by 16.70% the S&P500.

Cryo-Cell International, Inc. engages in cellular processing and cryogenic cellular storage with focus on the collection and preservation of umbilical cord blood stem cells for family use. The company has market cap of $60.66 million. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. It has a 25.96 P/E ratio. The firm also makes and sells Prepacyte CB units, a technology used to process umbilical cord blood stem cells.

The stock increased 2.07% or $1.55 during the last trading session, reaching $76.4. About 326,351 shares traded. Wix.com Ltd. (NASDAQ:WIX) has risen 188.42% since February 21, 2017 and is uptrending. It has outperformed by 171.72% the S&P500.

Investors sentiment increased to 0.96 in Q3 2017. Its up 0.15, from 0.81 in 2017Q2. It increased, as 37 investors sold Wix.com Ltd. shares while 35 reduced holdings. 18 funds opened positions while 51 raised stakes. 34.13 million shares or 14.13% more from 29.90 million shares in 2017Q2 were reported. Schroder Inv Mgmt Group reported 45,058 shares. Wells Fargo & Mn accumulated 0.01% or 436,201 shares. 41,118 were reported by Boothbay Fund Ltd. Hsbc Holdings Public Lc stated it has 0% in Wix.com Ltd. (NASDAQ:WIX). Deutsche Retail Bank Ag has invested 0% of its portfolio in Wix.com Ltd. (NASDAQ:WIX). 18,880 are held by Nationwide Fund Advisors. Pdts Prtnrs Llc reported 0.89% in Wix.com Ltd. (NASDAQ:WIX). Geode Mgmt Limited Company owns 0% invested in Wix.com Ltd. (NASDAQ:WIX) for 28,338 shares. Blackrock has 868,224 shares for 0% of their portfolio. D E Shaw And Com Inc stated it has 5,635 shares or 0% of all its holdings. Fund Mgmt accumulated 249,196 shares. Investors holds 1.04M shares or 0.02% of its portfolio. Granahan Inv Inc Ma reported 1.19% stake. Fmr Limited has invested 0.03% in Wix.com Ltd. (NASDAQ:WIX). Credit Suisse Ag, a Switzerland-based fund reported 22,041 shares.

Wix.com Ltd. develops and markets an Internet service that allows users to create Web content in Latin America, Europe, North America, Asia, and internationally. The company has market cap of $3.47 billion. It offers Web development, design, and management solutions and apps through an online platform that enables its user base of businesses, organizations, professionals, and individuals to create a digital presence. It currently has negative earnings. The company??s principal product is the Wix Editor, a drag-and-drop visual development and Website editing environment.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: